Good morning, and welcome to Hinge Health, Inc.'s 2026 Annual Meeting of Stockholders. Please note that this event is being held via live webcast, and the webcast will be posted on the company's website for one year after the meeting. I would now like to turn the meeting over to Daniel Perez, Chief Executive Officer and Co-founder, and Chairperson of the annual meeting.
Welcome, everyone, and thank you for joining us for our 2026 Annual Meeting of Stockholders. I'm Daniel Perez, Co-founder and CEO of Hinge Health, and I will act as the chairperson of today's meeting, and I'll call the meeting to order. We're pleased to host this year's annual meeting virtually, and we believe this format helps increase stockholder participation. Manoj Dodge, our Lead Counsel, Corporate and Securities, and Corporate Secretary, is serving as Secretary of the meeting and will keep the official minutes. This meeting is being recorded. No attendees are permitted to use any personal audio recording device. A replay will be available within 24 hours at Hinge Health's Investor Relations page at ir.hingehealth.com and will remain accessible for one year.
The Inspector of Elections has confirmed that the holders of a majority of the voting power of our stock issued and outstanding and entitled to vote at this meeting are present or represented by proxy. A quorum is therefore present. It is 9:01 AM. Pacific, and the polls are now open. Voting is by proxy and electronic ballot. If you haven't yet voted or wish to change your vote, click the Vote button on the webcast portal and follow the instructions. If you've already submitted your proxy or voted online or by phone and don't wish to make changes, no further action is needed. Your vote will be counted automatically. We expect to close the polls approximately one minute after the proposals have been presented. We will answer -questions regarding the proposals to be voted on at the meeting after all proposals have been presented, as appropriate.
To submit a question, enter it in writing on the webcast portal. Only validated stockholders with a 16-digit control number may submit questions. Stockholders are limited to one question each, and questions should relate to the proposals being voted on. We'll address as many relevant questions as we can within 10 minutes. We may need to move on from any question that runs unreasonably long. In addition to myself, all members of our board of directors are joining us today. We're also joined by members of senior management, including Jim Pursley, our President; James Budge, our CFO; George Kanave, our General Counsel; and Bianca Buck, our Head of Investor Relations. Also present are John Burwise and Kelsey Wan of Deloitte & Touche, our independent registered public accounting firm, who will be available during the question -and -answer session to respond to appropriate questions.
Lexi Smith of Fenwick & West, our outside securities counsel, and Tony Carideo of the Carideo Group, the Inspector of Elections, who has executed the Oath of Inspector of Elections, will act as the Inspector of Elections for this meeting and tabulate the voting results. Let's turn to the formal business of the meeting. The proposals to be considered are described in our proxy statement dated April 17, 2026. I'll walk through each one shortly. First, I'll report on the notice for this meeting. Our board fixed April 10th, 2026, as the record date for determining the stockholders entitled to vote. I present to this meeting an affidavit provided by Broadridge, attesting that a notice of Internet availability of proxy materials was mailed on or about April 17, 2026, to all stockholders of record as of the close of business on the record date.
This affidavit will be incorporated into the minutes of this meeting. Pursuant to Delaware General Corporation Law, Section 219, a list of stockholders entitled to vote was available for examination by any stockholder during ordinary business hours at our headquarters for the 10-day period ending June 2nd, 2026. As of the record date, the following shares are outstanding and entitled to vote: 54,642,751 shares of Class A common stock, one vote per share; 22,730,358 shares of Class B common stock, 15 votes per share; and 2,581,837 shares of Series E preferred stock, votes based on the number of shares of common stock into which each Series E share is convertible, except that Series E shares are not entitled to vote on the election of directors. As I noted, the Inspector of Elections has confirmed that a quorum is present, and we are authorized to transact business.
I will now present the matters to be voted upon. Proposal one is the election of directors. The first item of business is the election of Teddie Wardi and Tyler Sloat, our nominees for Class I directors, to serve until our 2029 annual meeting of stockholders and until each director's successor is duly elected and qualified, or until such director's earlier death, resignation, disqualification, retirement, or removal. No other director nominees have been properly submitted pursuant to our amended and restated bylaws or SEC rules. Therefore, no other nominations may be accepted. The Board recommends a vote for the election of each nominated director. On behalf of the Board of Directors, I move for the election of each of the nominated directors. This motion is seconded by proxy.
The second item of business is to ratify the appointment of Deloitte as our independent registered public accounting firm for the year ending December 31st, 2026. The board recommends a vote for the ratification of this appointment. On behalf of the board of directors, I move for the approval of this proposal. This motion is seconded by proxy. We'll now address any questions stockholders have submitted that are relevant to the proposals. As a reminder, each stockholder is limited to one question, and the Q&A session will be limited to 10 minutes. If no relevant questions have been received, we'll move directly to voting.
We haven't received any questions, and will now proceed to vote on the proposals. As noted earlier, the voting today is by proxy and electronic ballot. Any stockholder who has not voted or wishes to change his or her vote may do so by clicking the Vote button on the webcast portal and following the instructions there. Stockholders who have sent in proxies or previously voted via the internet or by phone or who do not wish to change their vote do not need to take further action. Their votes will be counted automatically. We expect to leave the polls open for approximately one minute to allow anyone who chooses to vote here to cast ballots. Time begins now for brief thought.
Three, two, one.
It is 9:08 AM. Pacific. Now that everyone has had the opportunity to vote, I now declare the polls for the annual meeting of Hinge Health closed at 9:08 AM. on June 3rd, 2026. The Inspector of Elections has provided the voting results. Directors are elected by plurality of the votes cast, meaning the two class 1 nominees receiving the highest number of For votes will be elected. Based on the inspector's tabulation, Teddie Wardi and Tyler Sloat each received the highest number of For votes and have been elected to the board of directors. For proposal two, ratification and appointment of independent registered public accounting firm. This proposal requires the affirmative vote of the holders of the majority of the voting power of the votes cast present or represented by proxy and entitled to vote on the matter.
The ratification of the appointment of Deloitte will be obtained if the number of votes for exceeds the number of votes against. Based on the inspector's tabulation, the proposal to ratify the appointment of Deloitte has been approved. The annual meeting is now adjourned. Final voting results will be recorded in the minutes and filed with the SEC on a current report on Form 8-K within four business days. Thank you for your participation.
The 2026 annual meeting of stockholders of Hinge Health has now come to an end. A replay will be available within 24 hours at ir.hingehealth.com. Thank you for attending.